192 related articles for article (PubMed ID: 27084515)
1. Pilot study of biological monitoring of four antineoplastic drugs among Canadian healthcare workers.
Poupeau C; Tanguay C; Plante C; Gagné S; Caron N; Bussières JF
J Oncol Pharm Pract; 2017 Jul; 23(5):323-332. PubMed ID: 27084515
[TBL] [Abstract][Full Text] [Related]
2. Quantification of healthcare workers' exposure to cyclophosphamide, ifosfamide, methotrexate, and 5-fluorouracil by 24-h urine assay: A descriptive pilot study.
Palamini M; Dufour A; Therrien R; Delisle JF; Mercier G; Gagné S; Caron N; Bussières JF
J Oncol Pharm Pract; 2020 Dec; 26(8):1864-1870. PubMed ID: 32138611
[TBL] [Abstract][Full Text] [Related]
3. Biological monitoring of occupational exposure to antineoplastic drugs in hospital settings.
Sabatini L; Barbieri A; Lodi V; Violante FS
Med Lav; 2012; 103(5):394-401. PubMed ID: 23077799
[TBL] [Abstract][Full Text] [Related]
4. Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers.
Sessink PJ; Boer KA; Scheefhals AP; Anzion RB; Bos RP
Int Arch Occup Environ Health; 1992; 64(2):105-12. PubMed ID: 1399019
[TBL] [Abstract][Full Text] [Related]
5. [Occupational exposures among nurses caring for chemotherapy patients -Quantitative analysis of cyclophosphamide and α-fluoro-β-alanine in urine].
Sasaki M; Ishii N; Kikuchi Y; Kudoh Y; Sugiyama R; Hasebe M
Sangyo Eiseigaku Zasshi; 2016 Oct; 58(5):164-172. PubMed ID: 27488511
[TBL] [Abstract][Full Text] [Related]
6. Study protocol for the assessment of nurses internal contamination by antineoplastic drugs in hospital centres: a cross-sectional multicentre descriptive study.
Villa A; Molimard M; Bignon E; Martinez B; Rouyer M; Mathoulin-Pelissier S; Baldi I; Verdun-Esquer C; Canal-Raffin M
BMJ Open; 2019 Nov; 9(11):e033040. PubMed ID: 31712349
[TBL] [Abstract][Full Text] [Related]
7. Multicenter study of environmental contamination with cyclophosphamide, ifosfamide, and methotrexate in 66 Canadian hospitals: A 2016 follow-up study.
Roland C; Caron N; Bussières JF
J Occup Environ Hyg; 2017 Aug; 14(8):661-669. PubMed ID: 28574754
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of environmental contaminations and occupational exposures involved in preparation of chemotherapeutic drugs.
Maeda S; Miyawaki K; Matsumoto S; Oishi M; Miwa Y; Kurokawa N
Yakugaku Zasshi; 2010 Jun; 130(6):903-10. PubMed ID: 20519870
[TBL] [Abstract][Full Text] [Related]
9. Nurses' internal contamination by antineoplastic drugs in hospital centers: a cross-sectional descriptive study.
Villa A; Molimard M; Sakr D; Lassalle R; Bignon E; Martinez B; Rouyer M; Mathoulin-Pelissier S; Baldi I; Verdun-Esquer C; Canal-Raffin M
Int Arch Occup Environ Health; 2021 Nov; 94(8):1839-1850. PubMed ID: 34021808
[TBL] [Abstract][Full Text] [Related]
10. Biological monitoring of cyclophosphamide and ifosfamide in urine of hospital personnel occupationally exposed to cytostatic drugs.
Ensslin AS; Stoll Y; Pethran A; Pfaller A; Römmelt H; Fruhmann G
Occup Environ Med; 1994 Apr; 51(4):229-33. PubMed ID: 8199663
[TBL] [Abstract][Full Text] [Related]
11. Multicenter study of environmental contamination with cyclophosphamide, ifosfamide, and methotrexate in 48 Canadian hospitals.
Poupeau C; Tanguay C; Caron NJ; Bussières JF
J Oncol Pharm Pract; 2018 Jan; 24(1):9-17. PubMed ID: 27799608
[TBL] [Abstract][Full Text] [Related]
12. Occupational Exposure to Antineoplastic Drugs in Twelve French Health Care Setting: Biological Monitoring and Surface Contamination.
Ndaw S; Remy A
Int J Environ Res Public Health; 2023 Mar; 20(6):. PubMed ID: 36981860
[TBL] [Abstract][Full Text] [Related]
13. Using a closed-system protective device to reduce personnel exposure to antineoplastic agents.
Wick C; Slawson MH; Jorgenson JA; Tyler LS
Am J Health Syst Pharm; 2003 Nov; 60(22):2314-20. PubMed ID: 14652980
[TBL] [Abstract][Full Text] [Related]
14. Antineoplastic drug contamination in the urine of Canadian healthcare workers.
Hon CY; Teschke K; Shen H; Demers PA; Venners S
Int Arch Occup Environ Health; 2015 Oct; 88(7):933-41. PubMed ID: 25626912
[TBL] [Abstract][Full Text] [Related]
15. Biological monitoring of hospital personnel occupationally exposed to antineoplastic agents.
Turci R; Sottani C; Ronchi A; Minoia C
Toxicol Lett; 2002 Aug; 134(1-3):57-64. PubMed ID: 12191861
[TBL] [Abstract][Full Text] [Related]
16. Biological monitoring of occupational exposure to 5-fluorouracil: urinary α-fluoro-β-alanine assay by high performance liquid chromatography tandem mass spectrometry in health care personnel.
Ndaw S; Denis F; Marsan P; d'Almeida A; Robert A
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(27):2630-4. PubMed ID: 20207593
[TBL] [Abstract][Full Text] [Related]
17. Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital.
Hedmer M; Tinnerberg H; Axmon A; Jönsson BA
Int Arch Occup Environ Health; 2008 Jul; 81(7):899-911. PubMed ID: 18066576
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of early DNA damage in healthcare workers handling antineoplastic drugs.
Ursini CL; Cavallo D; Colombi A; Giglio M; Marinaccio A; Iavicoli S
Int Arch Occup Environ Health; 2006 Nov; 80(2):134-40. PubMed ID: 16761155
[TBL] [Abstract][Full Text] [Related]
19. Surface contamination with ten antineoplastic drugs in 83 Canadian centers.
Chauchat L; Tanguay C; Caron NJ; Gagné S; Labrèche F; Bussières JF
J Oncol Pharm Pract; 2019 Jul; 25(5):1089-1098. PubMed ID: 29726786
[TBL] [Abstract][Full Text] [Related]
20. Cross-sectional evaluation of surface contamination with 9 antineoplastic drugs in 93 Canadian healthcare centers: 2019 results.
Palamini M; Gagné S; Caron N; Bussières JF
J Oncol Pharm Pract; 2020 Dec; 26(8):1921-1930. PubMed ID: 32114883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
